Skip to main content
Erschienen in: Endocrine 2/2023

12.06.2023 | Original Article

Iodine status and its association with prevalence of thyroid diseases in adults from Jiangxi Province, China

verfasst von: Di-en Yan, Lei Hu, Yun-feng Shen, Xiao-yang Lai, Mei-ying Zhang, Min Zhou, Chao Chen, Mei-mei Liu, Li-ting Wu, Li-qun Liu, Qi-wei Fan, Wen-lan Min, Si-cong Wan, Fang Zou, Jing Li, Xia Cai, Shui-hong Lei, Yan Xiong, Ya Yang, Rong Yu, Wei-wei Gao, Ying Zhang, Ting Chen

Erschienen in: Endocrine | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Iodine is an essential element for the biosynthesis of thyroid-stimulating hormone (TSH). Both excessive and deficient iodine are major risk factors for thyroid diseases, including thyroid dysfunction, thyroid nodules, and thyroid autoimmunity (TAI). This study aimed to elucidate the relationship between iodine status and the prevalence of thyroid diseases through a national cross-sectional epidemiological survey in Jiangxi province (China).

Methods

This population-based, cross-sectional study enrolled 2636 Chinese local inhabitants who aged over 18 years old from April to August in 2015. Physical examination was performed and biochemical indices, urinary iodine concentration (UIC), and TSH level were measured. The Chi-square test, nonparametric test, and 4 multivariate logistic regression models adjusted for risk factors were applied to analysis. Spearman correlation coefficients were calculated to investigate the relationship between iodine intake level and the prevalence of thyroid diseases.

Results

The median UIC was 176.4 μg/L, and a significant difference was found in median UIC between men (182.45 μg/L) and women (169.25 μg/L) (P = 0.03). Among these study subjects, 14.4%, 44.5%, 26.1%, and 15.0% had deficient, adequate, more than adequate, and excessive iodine concentrations, respectively. The prevalence rates of hyperthyroidism, subclinical hyperthyroidism, hypothyroidism, subclinical hypothyroidism, thyroid nodules, and TAI were 0.91%, 0.57%, 0.34% and 7.89%, 9.45%, and 12.7%, respectively. Significant differences were found in iodine status, waist circumstance, systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), TSH, thyroid nodules, and TAI between men and women (P < 0.05). Compared with those with adequate UIC, subjects with excessive UIC had higher prevalence rates of thyroid dysfunction (odds ratio (OR) = 1.74, 95% confidence interval (CI): 1.40–2.54) and thyroid nodules (OR = 3.33, 95%CI 1.32–8.42). In addition, subjects with deficient and excessive UIC were at the higher risk of TAI compared with those with adequate UIC (OR = 1.68, 95%CI: 1.19–2.60; OR = 1.52, 95%CI: 1.04–2.96, respectively). UIC was positively correlated with the prevalence rates of thyroid nodules (r = −0.44, P < 0.01) and TAI (r = −0.055, P < 0.01). On the contrary, UIC was negatively correlated with the risk of thyroid dysfunction (r = −0.24, P > 0.05).

Conclusion

Adult inhabitants from Jiangxi province in the TIDE study were in the adequate iodine status. Excessive iodine status was noted as a risk factor for thyroid dysfunction and thyroid nodules. In addition, both iodine deficiency and excessive iodine were risk factors for TAI.
Literatur
1.
Zurück zum Zitat S. Kim et al. Association between iodine nutrition status and thyroid disease-related hormone in Korean adults: Korean national health and nutrition examination survey VI (2013-2015). Nutrients 11(11), 2757 (2019)CrossRefPubMedPubMedCentral S. Kim et al. Association between iodine nutrition status and thyroid disease-related hormone in Korean adults: Korean national health and nutrition examination survey VI (2013-2015). Nutrients 11(11), 2757 (2019)CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat J. Santos et al. Iodine fortification of foods and condiments, other than salt, for preventing iodine deficiency disorders. Cochrane Database Syst. Rev. 2, CD010734 (2019)PubMed J. Santos et al. Iodine fortification of foods and condiments, other than salt, for preventing iodine deficiency disorders. Cochrane Database Syst. Rev. 2, CD010734 (2019)PubMed
3.
Zurück zum Zitat H. Xu et al. Global, regional, and national burdens of common micronutrient deficiencies from 1990 to 2019: A secondary trend analysis based on the Global Burden of Disease 2019 study. EClinicalMedicine 44, 101299 (2022)CrossRef H. Xu et al. Global, regional, and national burdens of common micronutrient deficiencies from 1990 to 2019: A secondary trend analysis based on the Global Burden of Disease 2019 study. EClinicalMedicine 44, 101299 (2022)CrossRef
4.
Zurück zum Zitat H. Chen, J. Lu, Y. Li, Secular trends in the prevalence of and disability-adjusted life years due to common micronutrient deficiencies in China from 1990 to 2019: an age-period-cohort study and joinpoint analysis. Front Nutr. 9, 754351 (2022)CrossRefPubMedPubMedCentral H. Chen, J. Lu, Y. Li, Secular trends in the prevalence of and disability-adjusted life years due to common micronutrient deficiencies in China from 1990 to 2019: an age-period-cohort study and joinpoint analysis. Front Nutr. 9, 754351 (2022)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Y. Zou et al. Iodine nutritional status after the implementation of the new iodized salt concentration standard in Zhejiang Province, China. BMC Public Health 14, 836 (2014)CrossRefPubMedPubMedCentral Y. Zou et al. Iodine nutritional status after the implementation of the new iodized salt concentration standard in Zhejiang Province, China. BMC Public Health 14, 836 (2014)CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Z. Yu et al. Iodine intake level and prevalence of thyroid disease in adults in Shaanxi province: a cross-sectional study. Ann. Transl. Med 9(20), 1567 (2021)CrossRefPubMedPubMedCentral Z. Yu et al. Iodine intake level and prevalence of thyroid disease in adults in Shaanxi province: a cross-sectional study. Ann. Transl. Med 9(20), 1567 (2021)CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat E. Frohlich, R. Wahl, Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 8, 521 (2017)CrossRefPubMedPubMedCentral E. Frohlich, R. Wahl, Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases. Front Immunol. 8, 521 (2017)CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat W. Teng et al. Effect of iodine intake on thyroid diseases in China. N. Engl. J. Med. 354(26), 2783–2793 (2006)CrossRefPubMed W. Teng et al. Effect of iodine intake on thyroid diseases in China. N. Engl. J. Med. 354(26), 2783–2793 (2006)CrossRefPubMed
9.
Zurück zum Zitat J. Bertinato, Iodine nutrition: Disorders, monitoring and policies. Adv. Food Nutr. Res 96, 365–415 (2021)CrossRefPubMed J. Bertinato, Iodine nutrition: Disorders, monitoring and policies. Adv. Food Nutr. Res 96, 365–415 (2021)CrossRefPubMed
10.
Zurück zum Zitat Y. Li et al. Efficacy and safety of long-term universal salt iodization on thyroid disorders: epidemiological evidence from 31 provinces of Mainland China. Thyroid 30, 568–579 (2020)CrossRefPubMed Y. Li et al. Efficacy and safety of long-term universal salt iodization on thyroid disorders: epidemiological evidence from 31 provinces of Mainland China. Thyroid 30, 568–579 (2020)CrossRefPubMed
11.
Zurück zum Zitat X. Sun, Z. Shan, W. Teng, Effects of increased iodine intake on thyroid disorders. Endocrinol. Metab. 29, 240–247 (2014)CrossRef X. Sun, Z. Shan, W. Teng, Effects of increased iodine intake on thyroid disorders. Endocrinol. Metab. 29, 240–247 (2014)CrossRef
12.
Zurück zum Zitat B. Ren et al. Distributions of serum thyroid-stimulating hormone in 2020 thyroid disease-free adults from areas with different iodine levels: a cross-sectional survey in China. J. Endocrinol. Invest 44, 1001–1010 (2021)CrossRefPubMed B. Ren et al. Distributions of serum thyroid-stimulating hormone in 2020 thyroid disease-free adults from areas with different iodine levels: a cross-sectional survey in China. J. Endocrinol. Invest 44, 1001–1010 (2021)CrossRefPubMed
13.
Zurück zum Zitat P. Laurberg et al. The TSH upper reference limit: where are we at? Nature reviews. Endocrinology 7(4), 232–239 (2011)PubMed P. Laurberg et al. The TSH upper reference limit: where are we at? Nature reviews. Endocrinology 7(4), 232–239 (2011)PubMed
14.
Zurück zum Zitat J.M.B. Farebrother, Zimmermann, M. Andersson, Excess iodine intake: sources, assessment, and effects on thyroid function. Ann. NY Acad. Sci. 1446(1), 44–65 (2019)CrossRefPubMed J.M.B. Farebrother, Zimmermann, M. Andersson, Excess iodine intake: sources, assessment, and effects on thyroid function. Ann. NY Acad. Sci. 1446(1), 44–65 (2019)CrossRefPubMed
15.
Zurück zum Zitat S. Cui et al. Iodine Intake Increases IP-10 Expression in the Serum and Thyroids of Rats with Experimental Autoimmune Thyroiditis. Int J. Endocrinol. 2014, 581069 (2014)CrossRefPubMedPubMedCentral S. Cui et al. Iodine Intake Increases IP-10 Expression in the Serum and Thyroids of Rats with Experimental Autoimmune Thyroiditis. Int J. Endocrinol. 2014, 581069 (2014)CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Z. Shan et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid 26(8), 1125–1130 (2016)CrossRefPubMed Z. Shan et al. Iodine status and prevalence of thyroid disorders after introduction of mandatory universal salt iodization for 16 years in China: a cross-sectional study in 10 cities. Thyroid 26(8), 1125–1130 (2016)CrossRefPubMed
17.
Zurück zum Zitat C. Reiners et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 14(11), 926–932 (2004)CrossRefPubMed C. Reiners et al. Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 14(11), 926–932 (2004)CrossRefPubMed
18.
Zurück zum Zitat B. Zou et al. The prevalence of single and multiple thyroid nodules and its association with metabolic diseases in Chinese: a cross-sectional study. Int J. Endocrinol. 2020, 5381012 (2020)CrossRefPubMedPubMedCentral B. Zou et al. The prevalence of single and multiple thyroid nodules and its association with metabolic diseases in Chinese: a cross-sectional study. Int J. Endocrinol. 2020, 5381012 (2020)CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat J. Song et al. Prevalence of thyroid nodules and its relationship with iodine status in Shanghai: a population-based study. Biomed. Environ. Sci. 29(6), 398–407 (2016)PubMed J. Song et al. Prevalence of thyroid nodules and its relationship with iodine status in Shanghai: a population-based study. Biomed. Environ. Sci. 29(6), 398–407 (2016)PubMed
20.
Zurück zum Zitat X. Yu et al. A five-year follow-up study of goiter and thyroid nodules in three regions with different iodine intakes in China. J. Endocrinol. Invest 31(3), 243–250 (2008)CrossRefPubMed X. Yu et al. A five-year follow-up study of goiter and thyroid nodules in three regions with different iodine intakes in China. J. Endocrinol. Invest 31(3), 243–250 (2008)CrossRefPubMed
21.
Zurück zum Zitat S. Gaengler et al. Iodine status and thyroid nodules in females: a comparison of Cyprus and Romania. Public Health 143, 37–43 (2017)CrossRefPubMed S. Gaengler et al. Iodine status and thyroid nodules in females: a comparison of Cyprus and Romania. Public Health 143, 37–43 (2017)CrossRefPubMed
22.
Zurück zum Zitat B. Wang et al. U-shaped relationship between iodine status and thyroid autoimmunity risk in adults. Eur. J. Endocrinol. 181(3), 255–266 (2019)CrossRefPubMed B. Wang et al. U-shaped relationship between iodine status and thyroid autoimmunity risk in adults. Eur. J. Endocrinol. 181(3), 255–266 (2019)CrossRefPubMed
23.
Zurück zum Zitat S. Wan et al. Autoimmune thyroid diseases after 25 years of universal salt iodisation: an epidemiological study of Chinese adults in areas with different water iodine levels. Br. J. Nutr. 124(8), 853–864 (2020)CrossRefPubMed S. Wan et al. Autoimmune thyroid diseases after 25 years of universal salt iodisation: an epidemiological study of Chinese adults in areas with different water iodine levels. Br. J. Nutr. 124(8), 853–864 (2020)CrossRefPubMed
24.
Zurück zum Zitat F. Latrofa et al. Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. J. Clin. Endocrinol. Metab. 98(11), E1768–E1774 (2013)CrossRefPubMed F. Latrofa et al. Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. J. Clin. Endocrinol. Metab. 98(11), E1768–E1774 (2013)CrossRefPubMed
25.
26.
Zurück zum Zitat B. Deng et al. The relationship between metabolic parameters, age, and thyroid status: a cross-sectional study-based national survey of iodine nutrition, thyroid disease. Risk Manag Health. Policy 14, 1723–1730 (2021)CrossRef B. Deng et al. The relationship between metabolic parameters, age, and thyroid status: a cross-sectional study-based national survey of iodine nutrition, thyroid disease. Risk Manag Health. Policy 14, 1723–1730 (2021)CrossRef
27.
Zurück zum Zitat S. Shokri et al. Thyroid volume and nodular and diffuse thyroid diseases by ultrasonography in pregnant women: a case-control study. J. Res Med Sci. 25, 13 (2020)CrossRefPubMedPubMedCentral S. Shokri et al. Thyroid volume and nodular and diffuse thyroid diseases by ultrasonography in pregnant women: a case-control study. J. Res Med Sci. 25, 13 (2020)CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Y. Li et al. Effect of the transition from more than adequate iodine to adequate iodine on national changes in the prevalence of thyroid disorders: repeat national cross-sectional surveys in China. Eur. J. Endocrinol. 186(1), 115–122 (2021)CrossRefPubMedPubMedCentral Y. Li et al. Effect of the transition from more than adequate iodine to adequate iodine on national changes in the prevalence of thyroid disorders: repeat national cross-sectional surveys in China. Eur. J. Endocrinol. 186(1), 115–122 (2021)CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Y. Li et al. Estimated change in prevalence of abnormal thyroid-stimulating hormone levels in China according to the application of the kit-recommended or NACB standard reference interval. EClinicalMedicine 32, 100723 (2021)CrossRefPubMedPubMedCentral Y. Li et al. Estimated change in prevalence of abnormal thyroid-stimulating hormone levels in China according to the application of the kit-recommended or NACB standard reference interval. EClinicalMedicine 32, 100723 (2021)CrossRefPubMedPubMedCentral
Metadaten
Titel
Iodine status and its association with prevalence of thyroid diseases in adults from Jiangxi Province, China
verfasst von
Di-en Yan
Lei Hu
Yun-feng Shen
Xiao-yang Lai
Mei-ying Zhang
Min Zhou
Chao Chen
Mei-mei Liu
Li-ting Wu
Li-qun Liu
Qi-wei Fan
Wen-lan Min
Si-cong Wan
Fang Zou
Jing Li
Xia Cai
Shui-hong Lei
Yan Xiong
Ya Yang
Rong Yu
Wei-wei Gao
Ying Zhang
Ting Chen
Publikationsdatum
12.06.2023
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2023
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-023-03413-8

Weitere Artikel der Ausgabe 2/2023

Endocrine 2/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.